Surgical oncologic principles

Chest Surgery Clinics of North America

Volumn 11, Issue 1, 2001, Pages 1-16

  Goldstraw, P ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER PREVENTION; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; COST EFFECTIVENESS ANALYSIS; HUMAN; LUNG CANCER; PALLIATIVE THERAPY; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE;

FORECASTING; HUMANS; LUNG NEOPLASMS; PHYSICIAN'S ROLE; PRIMARY PREVENTION; THORACIC SURGERY; THORACIC SURGICAL PROCEDURES;

EID: 0035107111     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Improved survival in association with ARDS
2. Lobe-specific extent of systematic nodal dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis
3. The Development of Thoracic Anaesthesia
4. Historical perspective of lymphatic tumour spread and the emergence of the sentinel node concept
5. Radical lobectomy
6. Mediastinoscopy: A method of inspection and tissue biopsy in the superior mediastinum
7. Reactive oxygen species in acute lung injury
8. The surgical treatment of carcinoma of the lung
9. Phase III trial of neoadjuvant chemotherapy (NCT) in resectable stage 1 (except T1N0), II, IIIa non-small cell lung cancer (NSCLC): The French experience
10. Lung cancer and other causes of death in relation to smoking: A second report on the mortality of British doctors
11. The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer
12. Sites of recurrence in resected stage 1 non-small-cell lung cancer. A guide for future studies
13. The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging
14. Lung cancer screening. The Mayo program
15. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study
16. Intraoperative assessment of nodal staging at thoracotomy for carcinoma of the bronchus
17. Lung cancer: Future prospects
18. Modem thirty-day operative mortality for surgical resections in lung cancer
19. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group
20. Pulmonary resection: A modern phenomenon
21. Report on the international workshop on intrathoracic staging, London, October, 1996
22. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease)
23. The messages from recently completed trials on lung cancer
24. Pretreatment minimal staging for non-small cell lung cancer: An updated consensus report
25. Chemoprevention trials for lung cancer and future prospects
26. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer
27. Non-small cell lung cancer: Clinical value of new biological predictors
28. Lung injury in patients following thoracotomy
29. Early Lung Cancer Action Project: Overall design and findings from baseline screening
30. Prognostic value of malignant cells in pleural lavage at thoracotomy for bronchial carcinoma
31. Adjuvant treatment in resected lung cancer
32. 18F-Fluorodeoxyglucose PET scans in lung cancer
33. Chemotherapy for resectable stage III non-small-cell lung cancer - Can that dog hunt?
34. Should we insist on "radical pneumonectomy" as a routine procedure in the treatment of carcinoma of the lung?
35. The significance of pulmonary nodules detected on CT staging for lung cancer
36. Prognostic significance of pleural lavage cytology immediately after thoracotomy in patients with lung cancer
37. Lung cancer detection. Results of a randomized prospective study in Czechoslovakia
38. Selective use of PET scan in the preoperative staging of NSCLC
39. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device
40. Tumors and cysts of the lung
41. Survival related to nodal status after sleeve resection for lung cancer
42. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York
43. A new international staging system for lung cancer
44. Revisions in the international system for staging lung cancer
45. Towards dissection of the hilar structures and bronchial suture
46. Prognosis and survival in resected lung carcinoma based on the new international staging system
47. The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis
48. Pericardial drainage: Subxiphoid vs transthoracìc approach
49. An investigation into the lymphatic and vascular spread of carcinoma of the bronchus
50. The development of pulmonary surgery with special emphasis on carcinoma and bronchiectasis
51. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases
52. Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis
53. Lung cancer: The past twenty-five years
54. Bronchoscopic diathermy resection and stent insertion: A cost-effective treatment for tracheobronchial obstruction
55. The management of recurrent malignant pleural effusions: The complementary role of talc pleurodesis and pleuroperitoneal shunting
56. Postoperative radiotherapy in non-small-cell cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials
57. Cancer of the lung before 1900: A histologic review
58. Cancer of the lung from 1900 to 1930
59. Cancer of the lung 1930 to 1960: A review
60. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer
61. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
62. Hospital mortality and long-term survival after pulmonary resection in the elderly
63. Treatment of superior sulcus tumor by irradiation followed by resection
64. The significance of ipsilateral mediastinal lymph node metastasis (N2 disease) in non-small cell carcinoma of the lung. A commentary
65. Screening for lung cancer: Time to think positive
66. Mass screening for lung cancer with mobile spiral computed tomography scanner
67. A meta-analysis of adjuvant chemotherapy in non-small cell lung cancer (NSCLC) using updated individual patient data
68. Postoperative lung injury and oxidative damage in patients undergoing pulmonary resection
69. Management of ARDS